Document Detail


Effects of amylin on eating and adiposity.
MedLine Citation:
PMID:  22249817     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Amylin's best investigated function is to reduce eating via a meal size effect by promoting meal-ending satiation. This effect seems to depend on an activation of specific area postrema neurons. Brain areas that convey the neural signal to the forebrain include the nucleus of the solitary tract and the lateral parabrachial nucleus. Acute application of amylin modulates the activity of hypothalamic areas involved in the control of eating, namely, the lateral hypothalamic area and possibly the ventromedial hypothalamic nucleus. Amylin also interacts with other satiating signals, such as cholecystokinin, presumably in the brainstem. Interestingly, amylin also exhibits characteristics of adiposity signals; plasma levels of amylin are higher in obese individuals, chronic infusion of amylin into the brain reduces body weight gain and adiposity, and infusion of amylin antagonists increases adiposity. Furthermore, amylin maintains energy expenditure at higher levels than would be expected considering its body weight-lowering effect. However, much less is known (e.g., site of action, signaling pathways, differential activation of brain sites, and, most importantly, physiological relevance) with respect to its role as adiposity signal and regulator of energy expenditure than about its satiating action. Notwithstanding, and perhaps because amylin resistance does not seem to be a general and prohibitive concomitant of obesity, animal data and recent clinical data in humans indicate that amylin is a very promising candidate for the treatment of obesity. Amylin seems to be particularly effective when combined with other hormones such as leptin.
Authors:
Thomas Alexander Lutz
Related Documents :
3416617 - Effect of target contrast and luminance on soft contact lens and spectacle visual perfo...
9097317 - Pituitary adenoma revealed by paracentral junctional scotoma of traquair.
7425057 - Ocular quinine toxicity.
1635667 - The role of local contrast in the visual deficits of humans with naturally occurring am...
2674707 - Effects of different sensory inputs on the median-derived somatosensory evoked potential.
7560297 - Reduced nicotinamide adenine dinucleotide phosphate-diaphorase/nitric oxide synthase pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Handbook of experimental pharmacology     Volume:  209     ISSN:  0171-2004     ISO Abbreviation:  Handb Exp Pharmacol     Publication Date:  2012  
Date Detail:
Created Date:  2012-01-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902231     Medline TA:  Handb Exp Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  231-50     Citation Subset:  IM    
Affiliation:
Institute of Veterinary Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland, tomlutz@vetphys.uzh.ch.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CCK, PYY and PP: The Control of Energy Balance.
Next Document:  Intestinal microbiota and obesity.